$DROR

Dror Ortho-Design, Inc.

CIK:0001282980|SEC Filings

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Operating Expenses
Research and development	$ 150,769	$ 324,068	$ 269,179	$ 563,672
General and administrative expenses	344,997	391,494	723,781	705,123
Share-based compensation		15,977		39,170
Total Operating Expenses	495,766	731,539	992,960	1,307,965
Loss from operations	(495,766)	(731,539)	(992,960)	(1,307,965)
Financial Expenses, net	(10,967)	(15,107)	(8,714)	(14,804)
Amortization of debt discount	(75,362)	(14,595)	(236,787)	(14,595)
Change in fair value of derivative liability	(43,048)	1,903	(25,348)	1,903
Total other expense	(129,377)	(27,799)	(270,849)	(27,496)
Loss before provision for income taxes	(625,143)	(759,338)	(1,263,809)	(1,335,461)
Provision for income taxes
Net loss	$ (625,143)	$ (759,338)	$ (1,263,809)	$ (1,335,461)
Net loss per common share
Net loss per Common Stock, Basic (in Dollars per share)	$ (0)	$ (0)	$ (0)	$ (0)
Net loss per Common Stock, Diluted (in Dollars per share)	$ (0)	$ (0)	$ (0)	$ (0)
Weighted-average common shares outstanding
Weighted-average Common Stock outstanding, Basic (in Shares)	976,997,116	956,997,116	976,552,672	956,997,116
Weighted-average Common Stock outstanding, Diluted (in Shares)	976,997,116	956,997,116	976,552,672	956,997,116

Condensed Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net loss	$ (1,263,809)	$ (1,335,461)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense		39,170
Depreciation	2,629	2,450
Debt discount amortization	236,787	14,595
Change in fair value of derivative	25,348	(1,903)
Foreign exchange differences	5,453
Changes in operating assets and liabilities:
Receivables and prepaid expenses	(44,359)	42,696
Accounts payable	(10,607)	190,500
Accrued expenses and other payables	312,511	29,311
Accrued severance	27,028	33,679
Net cash used in operating activities	(709,019)	(984,963)
Cash flows from investing activities:
Purchase of property and equipment
Net cash used in investing activities
Net Cash flows from financing activities:
Proceeds from convertible promissory notes, net	575,000	500,000
Net cash provided by financing activities	575,000	500,000
Effect of exchange rate changes on cash and cash equivalents	(958)
Net decrease in cash	(134,977)	(484,963)
Cash, beginning of period	228,540	549,444
Cash, end of period	93,563	64,481
Supplemental cash flow information:
Cash paid for interest
Cash paid for taxes
Non cash transactions:
Shares issued in respect of future services	$ 200,000

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current Assets:
Cash	$ 93,563	$ 228,540
Receivables and prepaid expenses	254,593	10,234
Total Current Assets	348,156	238,774
Non-current Assets:
Property and equipment at cost, net of accumulated depreciation	17,533	20,162
Total Assets	365,689	258,936
Current Liabilities:
Accounts payable	102,978	113,585
Accrued expenses and other payables	609,554	292,548
Convertible promissory notes, net	1,873,777	1,308,229
Derivative liability	993,779	722,192
Registration Rights Agreement liability	520,000	520,000
Total Current Liabilities	4,100,088	2,956,554
Non-current Liabilities:
Accrued severance	203,121	176,093
Total Liabilities	4,303,209	3,132,647
Commitments and Contingencies (Note 7)
Stockholders’ Deficit
Preferred A Stock, $0.0001 par value, 12,500,000 shares authorized; 5,847,937 shares outstanding at June 30, 2026 and December 31, 2025	585	585
Common stock, $0.0001 par value; 3,254,475,740 shares authorized; 976,997,116 and 956,997,116 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively	97,699	95,699
Additional paid-in capital	19,279,548	19,081,548
Accumulated deficit	(23,315,352)	(22,051,543)
Total Stockholders’ Deficit	(3,937,520)	(2,873,711)
Total Liabilities and Stockholders’ Deficit	$ 365,689	$ 258,936